JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes

Blood Cancer J. 2022 Apr 8;12(4):56. doi: 10.1038/s41408-022-00646-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Janus Kinase 2* / genetics
  • Mutation
  • Polycythemia Vera* / diagnosis
  • Polycythemia Vera* / genetics
  • Primary Myelofibrosis*
  • Thrombocythemia, Essential* / diagnosis
  • Thrombocythemia, Essential* / genetics

Substances

  • JAK2 protein, human
  • Janus Kinase 2